SCHEMBL6566838

SCHEMBL6566838

O=C(CC1CC2CCC1C2)Nc1cc(Cl)c(O)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.53
LMNA P02545 2/20 0.52
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
RAB9A P51151 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
NPC1 O15118 1/20 0.47
HPGD P15428 2/20 0.44
SIRT5 Q9NXA8 1/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
RECQL P46063 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ECE1 P42892 1/20 0.41
P2RX5 Q93086 1/20 0.41
P2RX4 Q99571 1/20 0.41
P2RX2 Q9UBL9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1947945 0.87 LMNA (0.60) P2RX7LMNATDP1L3MBTL1RAB9A
SCHEMBL11732481 0.75 LMNA (0.59) P2RX7LMNATDP1L3MBTL1RAB9A
SCHEMBL6567255 0.75 EPHX2 (0.59) TDP1L3MBTL1RAB9AMEN1KMT2A
SCHEMBL6567675 0.70 P2RX7 (0.65) P2RX7MEN1KMT2AP2RX5P2RX4
SCHEMBL6781078 0.69 LDLR (0.59) LMNATDP1HPGDALDH1A1MAPT
SCHEMBL10582564 0.69 RAB9A (0.61) P2RX7LMNATDP1L3MBTL1RAB9A
SCHEMBL1785152 0.68 MEN1 (0.54) P2RX7LMNATDP1L3MBTL1RAB9A
SCHEMBL1785153 0.68 MEN1 (0.54) P2RX7LMNATDP1L3MBTL1RAB9A
SCHEMBL16150319 0.67 CYP3A4 (0.66) RAB9AMEN1KMT2AALDH1A1MAPT
SCHEMBL6568592 0.67 EPHX2 (0.54) P2RX7P2RX5P2RX4P2RX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed